Log in or Sign up for Free to view tailored content for your specialty!
Oncology News
Gore launches replacement program for migrating biliary stents
The manufacturer of the Gore Viabil short wire biliary endoprosthesis, a fully covered, self-expanding metal biliary stent, announced it has launched an anti-migration assurance program that will replace devices that migrate within a year of implantation.
Liver cancer remains a leading cause of cancer-related mortality worldwide
Primary liver cancer incidence increased by 75% between 1990 and 2015, and the disease remains one of the leading causes of cancer death in the world, according to a report from the Global Burden of Diseases Study 2015.
Log in or Sign up for Free to view tailored content for your specialty!
Nucleos(t)ide analogue reduces risk for liver cancer in HBV
Recently published data showed an association between nucleos(t)ide analogue therapy for chronic hepatitis B virus and a reduced risk for intrahepatic cholangiocarcinoma.
Liver transplant, cancer stage increase HCC care costs, survival time
A recently published analysis of veterans with hepatocellular carcinoma showed that receipt of liver transplantation, Barcelona Clinic Liver Cancer stage and multidisciplinary tumor board correlated with higher 3-year health care costs but increased survival time.
Liver cancer risk factors more prevalent among Mexicans living in US
Mexican-American individuals residing in the United States had more risk factors for liver cancer than their counterparts living in Mexico, according to study results presented at American Association for Cancer Research Conference on The Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved.
Muscle volume loss correlated with increased mortality in cirrhosis
Among patients with cirrhosis, muscle volume loss and hepatocellular carcinoma within Milan criteria were prognostic factors for mortality, according to recently published data.
FDA approves Opdivo for previously treated hepatocellular carcinoma
The FDA approved nivolumab for the treatment of patients with hepatocellular carcinoma who underwent prior therapy with sorafenib.
Reduced Nexavar dosage yields cost benefits, does not affect OS in HCC
Patients with hepatocellular carcinoma who started Nexavar therapy at reduced dosages had a lower total cumulative pill cost and were less likely to discontinue due to adverse effects, according to recently published data. Additionally, lower starting doses did not affect overall survival.
Gallbladder cancer linked to mold toxin
Dietary exposure to aflatoxin, or toxins produced by fungi affecting certain crops, may increase the risk for gallbladder cancer, according to new research.
HCC rates vary by race in US, highest among Asian-Pacific Islanders
Among U.S. veterans with hepatitis B, researchers found that the risk for hepatocellular carcinoma was higher among Asian-Pacific Islanders than Caucasians and African-Americans, increased with the presence of cirrhosis, and significantly increased among those without cirrhosis after age 40 regardless of race.
-
Headline News
We must make our voices heard and vote in the 2024 election
September 18, 20247 min read -
Headline News
Semaglutide improves glucose control in automated insulin delivery for type 1 diabetes
September 20, 20243 min read -
Headline News
Oncologists, primary care clinicians should be aware of BRCA testing indications in men
September 19, 20244 min read
-
Headline News
We must make our voices heard and vote in the 2024 election
September 18, 20247 min read -
Headline News
Semaglutide improves glucose control in automated insulin delivery for type 1 diabetes
September 20, 20243 min read -
Headline News
Oncologists, primary care clinicians should be aware of BRCA testing indications in men
September 19, 20244 min read